Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Fabian Dominik Mairinger"'
Autor:
Elena Mairinger, Michael Wessolly, Paul Buderath, Sabrina Borchert, Larissa Henrich, Pawel Mach, Julia Steinborn, Rainer Kimming, Bharat Jasani, Kurt Werner Schmid, Agnes Bankfalvi, Fabian Dominik Mairinger
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThe underlying mechanism of high T-cell presence as a favorable prognostic factor in high-grade serous ovarian carcinoma (HGSOC) is not yet understood. In addition to immune cells, various cofactors are essential for immune processes. One o
Externí odkaz:
https://doaj.org/article/61da0f0817b3496bb034186b8ace0936
Autor:
Thomas Hager, Sabrina Borchert, Michael Wessolly, Alexander Mathilakathu, Elena Mairinger, Jens Kollmeier, Thomas Mairinger, Balazs Hegedus, Kristina Greimelmaier, Jeremias Wohlschlaeger, Ken Herrmann, Fabian Dominik Mairinger
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 7, p 6356 (2023)
Malignant pleural mesothelioma (MPM) is a mainly asbestos-related tumour associated with a very poor prognosis. Therapeutic approaches include multimodal therapy and chemotherapeutics, with cisplatin being the drug of choice, but response rates of on
Externí odkaz:
https://doaj.org/article/af62e333fb3b4b25b1feb1a0f7945c79
Autor:
Michael Wessolly, Elena Mairinger, Sabrina Borchert, Agnes Bankfalvi, Pawel Mach, Kurt Werner Schmid, Rainer Kimmig, Paul Buderath, Fabian Dominik Mairinger
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundHigh-grade serous ovarian cancer (HGSOC) is the predominant and deadliest form of ovarian cancer. Some of its histological subtypes can be distinguished by frequent occurrence of cancer-associated myofibroblasts (CAFs) and desmoplastic stro
Externí odkaz:
https://doaj.org/article/2d03341162de4358a573bb7f97a982f0
Autor:
Robert Fred Henry Walter, Robert Werner, Claudia Vollbrecht, Thomas Hager, Elena Flom, Daniel Christian Christoph, Jan Schmeller, Kurt Werner Schmid, Jeremias Wohlschlaeger, Fabian Dominik Mairinger
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0165181 (2016)
Neuroendocrine lung cancer (NELC) represents 25% of all lung cancer cases and large patient collectives exist as formalin-fixed, paraffin-embedded (FFPE) tissue only. FFPE is controversially discussed as source for molecular biological analyses and r
Externí odkaz:
https://doaj.org/article/97c33fa24016449e86d1a9fefb362743
Autor:
Claudia Vollbrecht, Fabian Dominik Mairinger, Ulrike Koitzsch, Martin Peifer, Katharina Koenig, Lukas Carl Heukamp, Giuliano Crispatzu, Laura Wilden, Karl-Anton Kreuzer, Michael Hallek, Margarete Odenthal, Carmen Diana Herling, Reinhard Buettner
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0129544 (2015)
High resolution molecular studies have demonstrated that the clonal acquisition of gene mutations is an important mechanism that may promote rapid disease progression and drug resistance in chronic lymphocytic leukemia (CLL). Therefore, the early and
Externí odkaz:
https://doaj.org/article/6ad8741900c44a7e8f5cabb35c431fb3
Autor:
Thomas Herold, Wildfried E. E. Eberhardt, Pia-Maria Suckrau, Jeremias Wohlschlaeger, Clemens Aigner, Kurt Werner Schmid, Agnes Bankfalvi, Michael Wessolly, Fabian Dominik Mairinger, Robert Fred Henry Walter, Elena Mairinger, Balazs Hegedus, Thomas Hager, Sabrina Borchert
Publikováno v:
Journal of Oncology, Vol 2019 (2019)
Journal of Oncology
Journal of Oncology
Background. Malignant pleural mesothelioma (MPM) is a rare, predominantly asbestos-related and biologically highly aggressive tumor associated with a dismal prognosis. Multimodal therapy consisting of platinum-based chemotherapy is the treatment of c
Autor:
Sandra Christoph, Fabian Dominik Mairinger, Thomas Mairinger, Jeremias Wohlschlaeger, Robert Fred Henry Walter, Kurt Werner Schmid, Wilfried Eberhardt, Erika Berg, Jens Kollmeier, Saskia Roxanne Sydow, Daniel C. Christoph
Publikováno v:
Cancer Management and Research. 11:8711-8720
Background Bortezomib is an approved proteasome inhibitor for the treatment of certain lymphoma subtypes. Two clinical trials investigated bortezomib in patients with malignant pleural mesothelioma (MPM) and failed to improve outcome. We present a po
Autor:
Luka Brcic, Sabrina Borchert, Thomas Mairinger, Julia Steinborn, Robert Fred Henry Walter, Michael Wessolly, Hendrik Beckert, Fabian Dominik Mairinger, Jeremias Wohlschlaeger, Elena Mairinger, Thomas Hager, Daniel C. Christoph, Kurt Werner Schmid, Alexander Mathilakathu, Jens Kollmeier
Publikováno v:
Transl Lung Cancer Res
BACKGROUND: Malignant pleural mesothelioma (MPM) is a rare malignant tumor associated with asbestos exposure, with infaust prognosis and overall survival below 20 months in treated patients. Platinum is still the backbone of the chemotherapy protocol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e642138cbc12b2fc1a085c7b6a27fb0d
Autor:
Christoph Kleinschnitz, Aurel Popa-Wagner, Tanja Hussner, Fabian Dominik Mairinger, Tobias Tertel, Jonas Gregorius, Oumaima Stambouli, Chen Wang, Dongpei Yin, Fouzi El Magraoui, Verena Börger, Ayan Mohamud Yusuf, Dirk M. Hermann, Yachao Qi, Nina Hagemann, Robin Dittrich, Thorsten R. Doeppner, Matthias Gunzer, Yanis Mouloud, Bernd Giebel, Helmut E. Meyer
Publikováno v:
Basic Research in Cardiology
Obtained from the right cell-type, mesenchymal stromal cell (MSC)-derived small extracellular vesicles (sEVs) promote stroke recovery. Within this process, microvascular remodeling plays a central role. Herein, we evaluated the effects of MSC-sEVs on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bce1f59d613056390b7df7c7d1e949a8
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85107453149
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85107453149
Autor:
Elena Mairinger, Thomas Herold, Balazs Hegedus, Michael Wessolly, Robert Fred Henry Walter, Julia Steinborn, Thomas Hager, Fabian Dominik Mairinger, Sabrina Borchert, Kurt Werner Schmid, Clemens Aigner, Agnes Bankfalvi, Wilfried Eberhardt, Jeremias Wohlschlaeger, Pia-Maria Suckrau
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Malignant pleural mesothelioma (MPM) is a rare, but aggressive tumor with dismal prognosis. Platinum-based chemotherapy is regularly used as part of multimodality therapy. The expression of metallothioneins (MT) has been identified as a reason for ci